title: Ibrutinib for relapsed refractory hairy cell leukemia variant.
authors.affiliation: a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
authors.forename: Jan-Paul
authors.initials: JP
authors.lastname: Bohn
authors.affiliation: a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
authors.forename: David
authors.initials: D
authors.lastname: Wanner
authors.affiliation: a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
authors.forename: Michael
authors.initials: M
authors.lastname: Steurer
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D001706:Biopsy; D015897:Comorbidity; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D009367:Neoplasm Staging; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D019233:Retreatment; D016896:Treatment Outcome
chemical_list: D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine